» Articles » PMID: 37725139

Loop-mediated Isothermal Amplification Assay for Screening Congenital Cytomegalovirus Infection in Newborns

Abstract

Congenital cytomegalovirus (CMV) infection is a common cause of sensorineural hearing loss and neurodevelopmental impairment in newborns. However, congenital CMV infection cannot be diagnosed using samples collected more than 3 weeks after birth because testing after this time cannot distinguish between congenital infection and postnatal infection. Herein, we developed a robust loop-mediated isothermal amplification (LAMP) assay for the large-scale screening of newborns for congenital CMV infection. In contrast to conventional quantitative polymerase chain reaction (qPCR), which detects CMV within a dynamic range of 1.0 × 10 to 1.0 × 10 copies/μL, our quantitative LAMP assay (qLAMP) detects CMV within a dynamic range of 1.1 × 10 to 1.1 × 10 copies/μL. Moreover, the turnaround time for obtaining results following DNA extraction is 90 min in qPCR but only 15 min in qLamp. The colorimetric LAMP assay can also detect CMV down to 1.1 × 10 copies/μL within 30 min, irrespective of the type of heat source. Our LAMP assay can be utilized in central laboratories as an alternative to conventional qPCR for quantitative CMV detection, or for point-of-care testing in low-resource environments, such as developing countries, via colorimetric naked-eye detection. KEY POINTS: • LAMP assay enables large-scale screening of newborns for congenital CMV infection. • LAMP allows colorimetric or quantitative detection of congenital CMV infection. • LAMP assay can be used as a point-of-care testing tool in low-resource environments.

Citing Articles

Advancements in LAMP-Based Diagnostics: Emerging Techniques and Applications in Viral Detection with a Focus on Herpesviruses in Transplant Patient Management.

Gomes Torres A, Mathias C, Baal S, Kohler A, Cunha M, Blanes L Int J Mol Sci. 2024; 25(21).

PMID: 39519059 PMC: 11546353. DOI: 10.3390/ijms252111506.

References
1.
Bristow B, OKeefe K, Shafir S, Sorvillo F . Congenital cytomegalovirus mortality in the United States, 1990-2006. PLoS Negl Trop Dis. 2011; 5(4):e1140. PMC: 3082510. DOI: 10.1371/journal.pntd.0001140. View

2.
Nguyen H, Nguyen V, Nguyen H, Seo T . Quantification of colorimetric isothermal amplification on the smartphone and its open-source app for point-of-care pathogen detection. Sci Rep. 2020; 10(1):15123. PMC: 7493899. DOI: 10.1038/s41598-020-72095-3. View

3.
Fan Q, Nelson C, Bialas K, Chiuppesi F, Amos J, Gurley T . Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission. Clin Vaccine Immunol. 2017; 24(5). PMC: 5424243. DOI: 10.1128/CVI.00510-16. View

4.
Ronchi A, Shimamura M, Malhotra P, Sanchez P . Encouraging postnatal cytomegalovirus (CMV) screening: the time is NOW for universal screening!. Expert Rev Anti Infect Ther. 2017; 15(5):417-419. DOI: 10.1080/14787210.2017.1303377. View

5.
Rahav G, Gabbay R, Ornoy A, Shechtman S, Arnon J, Diav-Citrin O . Primary versus nonprimary cytomegalovirus infection during pregnancy, Israel. Emerg Infect Dis. 2008; 13(11):1791-3. PMC: 3375802. DOI: 10.3201/eid1311.061289. View